Primary study · included by 1 review

Dental implant surgery in patients in treatment with the anticoagulant oral rivaroxaban.

Gomez-Moreno 2016 (rivaroxaban) · Gómez-Moreno Gerardo, Aguilar-Salvatierra Antonio, Fernández-Cejas Esther, et al. · Clinical oral implants research · 2016

Included by

Postoperative Bleeding Complications Associated With Dental Implant Placement in Patients Receiving Antithrombotic Therapy: A Systematic Review and Meta-Analysis.

Non-Cochrane · intervention · 2025 · cited as Gomez-Moreno 2016 (rivaroxaban) · Table 2; Figure 3

Outcome this study informs	Pooled effect	Evidence	Certainty
Postoperative bleeding within three weeks of dental implant placement Continued antithrombotic therapy with local hemostatic measures vs Controls not receiving antithrombotic therapy · Within three weeks postoperatively	RR 4.47 [2.35, 8.51]	8 studies · 1792 participants	GRADE not reported
Postoperative bleeding within three weeks of dental implant placement Continued antithrombotic therapy with local hemostatic measures vs Controls not receiving antithrombotic therapy · Within three weeks postoperatively	RR 1.61 [0.93, 2.79]	4 studies · 954 participants	GRADE not reported

1 including review in total.